ArticleOphthalmology2012

Cost-effectiveness analysis of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.

Vinay Dewan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.